DiaMedica Therapeutics Inc. (DMAC)

NASDAQ:
DMAC
| Latest update: Apr 17, 2026, 4:45 AM

Stock events for DiaMedica Therapeutics, Inc. (DMAC)

N/A

Demand Seasonality affecting DiaMedica Therapeutics, Inc.’s stock price

N/A

Overview of DiaMedica Therapeutics, Inc.’s business

N/A

DMAC’s Geographic footprint

N/A

DMAC Corporate Image Assessment

N/A

Ownership

N/A

Price Chart

$6.62

0.61%
(1 month)

Top Shareholders

Omega Advisors, Inc.
3.88%
BlackRock, Inc.
3.65%
Paragon JV Partners LLC
1.68%
MLM Trust B
1.48%
Geode Holdings Trust
1.47%
The Vanguard Group, Inc.
1.39%
State Street Corp.
1.21%
Morgan Stanley
1.05%

Trade Ideas for DMAC

Today

Sentiment for DMAC

News
Social

Buzz Talk for DMAC

Today

Social Media

FAQ

What is the current stock price of DiaMedica Therapeutics, Inc.?

As of the latest update, DiaMedica Therapeutics, Inc.'s stock is trading at $6.62 per share.

What’s happening with DiaMedica Therapeutics, Inc. stock today?

Today, DiaMedica Therapeutics, Inc. stock is up by 0.61%, possibly due to news.

What is the market sentiment around DiaMedica Therapeutics, Inc. stock?

Current sentiment around DiaMedica Therapeutics, Inc. stock is positive, based on recent news, trading volume, and analyst opinions.

Is DiaMedica Therapeutics, Inc.'s stock price growing?

Over the past month, DiaMedica Therapeutics, Inc.'s stock price has increased by 0.61%.

How can I buy DiaMedica Therapeutics, Inc. stock?

You can buy DiaMedica Therapeutics, Inc. stock through any brokerage platform, such as e.g., Robinhood, Fidelity, E*TRADE, by searching for the ticker symbol DMAC

Who are the major shareholders of DiaMedica Therapeutics, Inc. stock?

Major shareholders of DiaMedica Therapeutics, Inc. include institutions such as Omega Advisors, Inc. (3.88%), BlackRock, Inc. (3.65%), Paragon JV Partners LLC (1.68%) ... , according to the latest filings.